Shenzhen Neptunus Bioengineering Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 20,238.374 million compared to CNY 17,865.681 million a year ago. Operating income was CNY 384.254 million compared to CNY 426.432 million a year ago. Net income was CNY 140.218 million compared to CNY 128.125 million a year ago. Basic earnings per share from continuing operations was CNY 0.051 compared to CNY 0.0464 a year ago.